Moreover, our findings suggest that even heterozygous gene variants that enhance TLR7 signaling may be sufficient to cause autoimmune disease, underscoring the importance of studies to define the prevalence of UNC93B1 mutations in patients with systemic autoimmunity and of systematically identifying additional negative regulators of this pathway. This evidence concerns the gene TLR7 and autoimmune disease.